ethyl 2,5-dihydroxycinnamate and Astrocytoma, Grade IV

ethyl 2,5-dihydroxycinnamate has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caday, CG; Han, Y; Nanda, A; Umezawa, K	1

Other Studies

1 other study(ies) available for ethyl 2,5-dihydroxycinnamate and Astrocytoma, Grade IV

Article	Year
Preferential inhibition of glioblastoma cells with wild-type epidermal growth factor receptors by a novel tyrosine kinase inhibitor ethyl-2,5-dihydroxycinnamate. Oncology research, 1997, Volume: 9, Issue:11-12 Topics: Cell Division; Cinnamates; DNA Replication; DNA, Neoplasm; Enzyme Inhibitors; ErbB Receptors; Glioblastoma; Humans; Molecular Weight; Phosphorylation; Protein-Tyrosine Kinases; Tumor Cells, Cultured	1997

Article

Year

Preferential inhibition of glioblastoma cells with wild-type epidermal growth factor receptors by a novel tyrosine kinase inhibitor ethyl-2,5-dihydroxycinnamate.

Oncology research, 1997, Volume: 9, Issue:11-12

Topics: Cell Division; Cinnamates; DNA Replication; DNA, Neoplasm; Enzyme Inhibitors; ErbB Receptors; Glioblastoma; Humans; Molecular Weight; Phosphorylation; Protein-Tyrosine Kinases; Tumor Cells, Cultured

1997